SMi European Pharmaceutical Pricing and Reimbursement

Oct. 28, 2009-Oct. 29, 2009
Marriott Courtyard Munich City Center
Munich, Germany
www.smi-online.co.uk/events/overview.asp?is=4&ref=3162

Description:

Lujing Wang, Senior Practice Executive, Managed Markets Practice, will present a session on evidence-based medicine in an evolving global landscape.

Abstract:

Evidence-Based Medicine in an Evolving Landscape for Global Market Access

Speakers:
Lujing Wang, Senior Practice Executive, Pricing and Reimbursement Practice, Campbell Alliance

The global landscape for market access is evolving and there are major trends taking hold that are reshaping the way payers and reimbursement bodies make reimbursement and coverage decisions.  In order to survive in this evolving environment, pharmaceutical companies must re-evaluate their current approach to access decision making, and begin thinking more strategically about how to address market access challenges.  This session will discuss   

  • The major trends that are shaping the global market access landscape
  • Key market access barriers and how they vary by geographic market and disease area
  • Increasing focus on evidence based medicine and HTA
  • The evolving requirement for evidence to support product reimbursement and access
  • How these trends are shaping pharmaceutical markets and how the evidence base is coming
  • Implications for pharmaceutical companies:
  • Key Takeaways for commercial planners

View Entire Event Calendar

Don't Miss